4DMEDICAL LIMITED (4DX)
AI Coverage Rating: Low
ASX AI Signals has generated 0 signals for 4DX during the last 90 days,
indicating low trading activity
4DX Share Price |
| Current Price | $4.250 |
| 52 Week High | $6.800 |
| 52 Week Low: | $0.230 |
| Trading at (% of 52 Week High) | 62.50% |
Volume
4405647
20 Day Avg
6561916
Relative Volume
67.1%
Business Overview
4DMedical Limited (ASX: 4DX) is a medical technology company that develops and commercializes imaging solutions to help diagnose lung diseases. Its flagship product, the XV Technology, provides advanced 4D lung imaging to improve respiratory health assessments. The company focuses on delivering innovative tools for healthcare professionals to enhance patient care.
ASX Sector Overview
Sector: Health Care Equipment & Services
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Latest AI Recommendation
Latest 4DMEDICAL LIMITED(4DX) News
16 Jun 2026, 10:06 PM
Expert panel will share real-world case studies to demonstrate how mobile CT screening, noninvasive CyPath® Lung testing, and comprehensive functional lung imaging can reduce cost while improving access, early detection and outcomes for veterans
National Association of Veterans' Research and Educat
25 Apr 2026, 12:06 PM
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
4DMedical (ASX:4DX) has signed a contract with GlaxoSmithKline to supply quantitative lung imaging analytics. The agreement focuses on using 4DMedical’s technology in GSK’s drug development p
20 Apr 2026, 10:35 PM
Virtual Investor Conferences
Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live at VirtualInvestorConferences.com
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor co
12 Dec 2021, 08:04 AM
The big shareholder groups in 4DMedical Limited (ASX:4DX) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. I quite like to see at least a little bit of insider ownership. As Charlie M
13 Sep 2021, 08:00 AM
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Having said that, unprofitable companies are risky because they could po
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial